chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 7.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Back pain, Blood test abnormal, Cardiac function test, Dysstasia, Full blood count
Clinical narrative: Initial report received on 08 January 2010 from the Centers for Disease Control (CDC), VAERS ID number 375179-1. A 7-year-old female patient had received a dose of Influenza A (H1N1) 2009 Monovalent Vaccine - Preservative (lot number UP09AA) on 15 December 2009. The patient had medical history/pre-existing conditions of asthma and sinusitis. The day after receiving the vaccination, the patient began experiencing backache and pain in the extremities. The following day, the patient could not stand on her own, and her parents took her to the hospital where she stayed for 2 days for observation and discharged with diagnosis of muscular pain and viral infection. Five days after vaccination, on 20 December 2009, the patient developed fever and was given ADVIL and acetaminophen suppository. The following day she was again taken to the hospital with fever, neck pain, backache and hematuria. She was started on SEPTRA treatment. On 22 December 2009, the patient was taken to her pediatrician who diagnosed her with GUILLAIN-BARRE syndrome due to performed reflex testing (result not reported) and blood test that revealed high protein levels. Other diagnostic tests included CBC, U/A, cardiac function test, and renal ultrasonography. None of the results were provided. The patient was treated with SOLUMEDROL, quickly improved and was discharged (date not reported) on PRELONE (10 cc for 5 days). At the time of this report the patient had recovered. Documents held by sender: None.
Age: 7.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Guillain-Barre syndrome, Haematuria, Myalgia, Neck pain, Pain in extremity
Clinical narrative: Initial report received on 08 January 2010 from the Centers for Disease Control (CDC), VAERS ID number 375179-1. A 7-year-old female patient had received a dose of Influenza A (H1N1) 2009 Monovalent Vaccine - Preservative (lot number UP09AA) on 15 December 2009. The patient had medical history/pre-existing conditions of asthma and sinusitis. The day after receiving the vaccination, the patient began experiencing backache and pain in the extremities. The following day, the patient could not stand on her own, and her parents took her to the hospital where she stayed for 2 days for observation and discharged with diagnosis of muscular pain and viral infection. Five days after vaccination, on 20 December 2009, the patient developed fever and was given ADVIL and acetaminophen suppository. The following day she was again taken to the hospital with fever, neck pain, backache and hematuria. She was started on SEPTRA treatment. On 22 December 2009, the patient was taken to her pediatrician who diagnosed her with GUILLAIN-BARRE syndrome due to performed reflex testing (result not reported) and blood test that revealed high protein levels. Other diagnostic tests included CBC, U/A, cardiac function test, and renal ultrasonography. None of the results were provided. The patient was treated with SOLUMEDROL, quickly improved and was discharged (date not reported) on PRELONE (10 cc for 5 days). At the time of this report the patient had recovered. Documents held by sender: None.
Age: 7.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Protein total increased, Pyrexia, Reflex test abnormal, Ultrasound kidney, Urine analysis
Clinical narrative: Initial report received on 08 January 2010 from the Centers for Disease Control (CDC), VAERS ID number 375179-1. A 7-year-old female patient had received a dose of Influenza A (H1N1) 2009 Monovalent Vaccine - Preservative (lot number UP09AA) on 15 December 2009. The patient had medical history/pre-existing conditions of asthma and sinusitis. The day after receiving the vaccination, the patient began experiencing backache and pain in the extremities. The following day, the patient could not stand on her own, and her parents took her to the hospital where she stayed for 2 days for observation and discharged with diagnosis of muscular pain and viral infection. Five days after vaccination, on 20 December 2009, the patient developed fever and was given ADVIL and acetaminophen suppository. The following day she was again taken to the hospital with fever, neck pain, backache and hematuria. She was started on SEPTRA treatment. On 22 December 2009, the patient was taken to her pediatrician who diagnosed her with GUILLAIN-BARRE syndrome due to performed reflex testing (result not reported) and blood test that revealed high protein levels. Other diagnostic tests included CBC, U/A, cardiac function test, and renal ultrasonography. None of the results were provided. The patient was treated with SOLUMEDROL, quickly improved and was discharged (date not reported) on PRELONE (10 cc for 5 days). At the time of this report the patient had recovered. Documents held by sender: None.
Age: 7.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Viral infection
Clinical narrative: Initial report received on 08 January 2010 from the Centers for Disease Control (CDC), VAERS ID number 375179-1. A 7-year-old female patient had received a dose of Influenza A (H1N1) 2009 Monovalent Vaccine - Preservative (lot number UP09AA) on 15 December 2009. The patient had medical history/pre-existing conditions of asthma and sinusitis. The day after receiving the vaccination, the patient began experiencing backache and pain in the extremities. The following day, the patient could not stand on her own, and her parents took her to the hospital where she stayed for 2 days for observation and discharged with diagnosis of muscular pain and viral infection. Five days after vaccination, on 20 December 2009, the patient developed fever and was given ADVIL and acetaminophen suppository. The following day she was again taken to the hospital with fever, neck pain, backache and hematuria. She was started on SEPTRA treatment. On 22 December 2009, the patient was taken to her pediatrician who diagnosed her with GUILLAIN-BARRE syndrome due to performed reflex testing (result not reported) and blood test that revealed high protein levels. Other diagnostic tests included CBC, U/A, cardiac function test, and renal ultrasonography. None of the results were provided. The patient was treated with SOLUMEDROL, quickly improved and was discharged (date not reported) on PRELONE (10 cc for 5 days). At the time of this report the patient had recovered. Documents held by sender: None.
Age: 27.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Asthenia, CSF protein increased, Guillain-Barre syndrome
Clinical narrative: Initial report received on 08 January 2010 from the Centers for Disease Control and Prevention, VAERS ID number  375606-1. A 27-year-old female patient received H1N1 (lot number UP024AA) on 23 November 2009. Ten days later, the patient experienced progressive weakness, presented to the emergency room, admitted, and was subsequently diagnosed with Guillain-Barre syndrome. Laboratory data was significant for an elevation in CSF protein (65). Recovery status was not reported. No further information was provided.
Age: 30.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Paraesthesia
Clinical narrative: Initial report received on 31 December 2009 from a health care professional. This non-serious case represents one of a cluster of 4 patients who experienced adverse events after H1N1- Preservative (lot number UP054AA). One of the four cases met seriousness criteria and is recorded in case number 2010-00026. Information regarding the other 2 non-serious cases are recorded in case numbers 2010-00024, and -00025. A 30-year-old female patient, who was recovering from a cold, received an intramuscular left deltoid injection of H1N1 - Preservative (lot number UP054AA) on 31 December 2009 at 13:40 pm. It was unknown if the patient was taking any concomitant medications at the time. Eighty minutes after receiving the vaccination, the patient called the reporter stating she was concerned that she had tingling in her left hand. The patient was contacted approximately three hours later as follow-up by the reporter, but the symptom was the same. It was not reported whether the patient required medical evaluation or treatment. At the time of this report, it was unknown if the patient had recovered. Follow-up information received on 06 January 2010 from a health care professional. The H1N1 - Preservative was the first dose the patient had received. The tingling in the hand started one hour post-vaccination (previously reported as 80 minutes post vaccination). A doctor visit was not required. Recovery status was reported as unknown. Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Paraesthesia
Clinical narrative: Initial report received on 31 December 2009 from a health care professional. This non-serious case represents one of a cluster of 4 patients who experienced adverse events after receiving H1N1 vaccine (lot number UP054AA). One of the four cases met seriousness criteria and is recorded in case number 2010-00026. Information regarding the other 2 non-serious cases are recorded in case numbers 2010-00023, and -00025. A 33-year-old male patient, who was recovering from a cold, received an intramuscular left deltoid injection of H1N1 vaccine (lot number UP054AA) on 31 December 2009 at 14:00 pm. It was unknown if the patient was taking any concomitant medications at the time. Within one hour post-vaccination (also reported as 15:00 pm), the patient's wife called concerned that the patient's left hand was tingling. The patient was contacted approximately 3 hours later as follow-up by the reporter, and there was no improvement in the symptoms. It was not reported whether the patient required medial evaluation or treatment. At the time of this report, it was unknown if the patient had recovered. Follow-up information received on 06 January 2010 from a health care professional. The H1N1 vaccine was the first dose the patient had received. It was clarified the tingling in the hand occurred one hour post-vaccination. No doctor visit was required. recovery status was reported as unknown. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: FLU(H1N1), FLUX(H1N1)
Symptoms: Computerised tomogram, Guillain-Barre syndrome, Hypoaesthesia, Laboratory test, Paraesthesia
Clinical narrative: Initial case received from the CDC on 08 January 2010, VAERS ID number 375691-1. A 32-year-old female patient received a dose of PANDEMIC INFLUENZA H1N1 VACCINE (manufacturer and lot number not reported) on 01 January 2010. The patient had a history of mitral valve prolapse and Factor V leiden mutation, and was taking BROMOCRIPTINE 1.25mg daily. The day of vaccination, she complained of numbness and tingling in both feet and legs below the knees. The symptoms progressed to numbness and tingling above the knee to the thigh area of one leg. It was reported that the patient had an ER visit. A CT scan and labs were performed (results were not reported). The doctor reported the event as mild Guillain-Barre Syndrome. Outcome performed was unknown. Documents held by sender: None
Age: 57.0
Sex: M
Vaccine: FLU(H1N1), FLU3, FLU(H1N1), FLU3
Symptoms: Asthenia, Cough, Dizziness, Gait disturbance, Guillain-Barre syndrome
Clinical narrative: Initial case received from the Centers for Disease Control and Prevention on 08 January 2010, VAERS ID number 375934-1. A 57-year-old male patient received FLUZONE (lot number U3271HA) and H1N1 vaccine (Novartis, lot number 10132A2P) on 12 December 2009. Medical history included hypertension and uncontrolled Diabetes Mellitus, and the patient was taking LISINOPRIL, TESSALON, and GLUCOBAN concomitantly. On 23 December 2009, 11 days post-vaccination, the patient developed waxing and waning dizziness, described as worse when coughing. She noted that she had been having cold symptoms for about 2 weeks (onset date not reported), and had seen her doctor and been prescribed antibiotics. The dizziness and a severe headache persisted, and so she visited the emergency room on an unspecified date. Upon presentation to the emergency room, she was noted to have weakness and difficulty walking, with moderate pain in the lower extremities. An MRI of the brain and spine were ordered; results were not reported. A neurology consult was performed, during which the patient was noted to have ascending paresis of the upper and lower extremities, clinically diagnosed as Guillain-Barre Syndrome following vaccination. She was transferred to the intensive care unit for close observation. Outcome was not reported. Documents held by sender: None.
Age: 57.0
Sex: M
Vaccine: FLU(H1N1), FLU3, FLU(H1N1), FLU3
Symptoms: Headache, Intensive care, Nasopharyngitis, Neurological examination, Nuclear magnetic resonance imaging
Clinical narrative: Initial case received from the Centers for Disease Control and Prevention on 08 January 2010, VAERS ID number 375934-1. A 57-year-old male patient received FLUZONE (lot number U3271HA) and H1N1 vaccine (Novartis, lot number 10132A2P) on 12 December 2009. Medical history included hypertension and uncontrolled Diabetes Mellitus, and the patient was taking LISINOPRIL, TESSALON, and GLUCOBAN concomitantly. On 23 December 2009, 11 days post-vaccination, the patient developed waxing and waning dizziness, described as worse when coughing. She noted that she had been having cold symptoms for about 2 weeks (onset date not reported), and had seen her doctor and been prescribed antibiotics. The dizziness and a severe headache persisted, and so she visited the emergency room on an unspecified date. Upon presentation to the emergency room, she was noted to have weakness and difficulty walking, with moderate pain in the lower extremities. An MRI of the brain and spine were ordered; results were not reported. A neurology consult was performed, during which the patient was noted to have ascending paresis of the upper and lower extremities, clinically diagnosed as Guillain-Barre Syndrome following vaccination. She was transferred to the intensive care unit for close observation. Outcome was not reported. Documents held by sender: None.
Age: 57.0
Sex: M
Vaccine: FLU(H1N1), FLU3, FLU(H1N1), FLU3
Symptoms: Nuclear magnetic resonance imaging brain, Pain in extremity, Paresis
Clinical narrative: Initial case received from the Centers for Disease Control and Prevention on 08 January 2010, VAERS ID number 375934-1. A 57-year-old male patient received FLUZONE (lot number U3271HA) and H1N1 vaccine (Novartis, lot number 10132A2P) on 12 December 2009. Medical history included hypertension and uncontrolled Diabetes Mellitus, and the patient was taking LISINOPRIL, TESSALON, and GLUCOBAN concomitantly. On 23 December 2009, 11 days post-vaccination, the patient developed waxing and waning dizziness, described as worse when coughing. She noted that she had been having cold symptoms for about 2 weeks (onset date not reported), and had seen her doctor and been prescribed antibiotics. The dizziness and a severe headache persisted, and so she visited the emergency room on an unspecified date. Upon presentation to the emergency room, she was noted to have weakness and difficulty walking, with moderate pain in the lower extremities. An MRI of the brain and spine were ordered; results were not reported. A neurology consult was performed, during which the patient was noted to have ascending paresis of the upper and lower extremities, clinically diagnosed as Guillain-Barre Syndrome following vaccination. She was transferred to the intensive care unit for close observation. Outcome was not reported. Documents held by sender: None.
Age: 57.0
Sex: M
Vaccine: FLU(H1N1), FLU3, FLU(H1N1), FLU3
Symptoms: Headache, Intensive care, Nasopharyngitis, Nuclear magnetic resonance imaging, Nuclear magnetic resonance imaging brain
Clinical narrative: Initial case received from the Centers for Disease Control and Prevention on 08 January 2010, VAERS ID number 375934-1. A 57-year-old male patient received FLUZONE (lot number U3271HA) and H1N1 vaccine (Novartis, lot number 10132A2P) on 12 December 2009. Medical history included hypertension and uncontrolled Diabetes Mellitus, and the patient was taking LISINOPRIL, TESSALON, and GLUCOBAN concomitantly. On 23 December 2009, 11 days post-vaccination, the patient developed waxing and waning dizziness, described as worse when coughing. She noted that she had been having cold symptoms for about 2 weeks (onset date not reported), and had seen her doctor and been prescribed antibiotics. The dizziness and a severe headache persisted, and so she visited the emergency room on an unspecified date. Upon presentation to the emergency room, she was noted to have weakness and difficulty walking, with moderate pain in the lower extremities. An MRI of the brain and spine were ordered; results were not reported. A neurology consult was performed, during which the patient was noted to have ascending paresis of the upper and lower extremities, clinically diagnosed as Guillain-Barre Syndrome following vaccination. She was transferred to the intensive care unit for close observation. Outcome was not reported. Documents held by sender: None.
Age: 57.0
Sex: M
Vaccine: FLU(H1N1), FLU3, FLU(H1N1), FLU3
Symptoms: Pain in extremity, Paresis
Clinical narrative: Initial case received from the Centers for Disease Control and Prevention on 08 January 2010, VAERS ID number 375934-1. A 57-year-old male patient received FLUZONE (lot number U3271HA) and H1N1 vaccine (Novartis, lot number 10132A2P) on 12 December 2009. Medical history included hypertension and uncontrolled Diabetes Mellitus, and the patient was taking LISINOPRIL, TESSALON, and GLUCOBAN concomitantly. On 23 December 2009, 11 days post-vaccination, the patient developed waxing and waning dizziness, described as worse when coughing. She noted that she had been having cold symptoms for about 2 weeks (onset date not reported), and had seen her doctor and been prescribed antibiotics. The dizziness and a severe headache persisted, and so she visited the emergency room on an unspecified date. Upon presentation to the emergency room, she was noted to have weakness and difficulty walking, with moderate pain in the lower extremities. An MRI of the brain and spine were ordered; results were not reported. A neurology consult was performed, during which the patient was noted to have ascending paresis of the upper and lower extremities, clinically diagnosed as Guillain-Barre Syndrome following vaccination. She was transferred to the intensive care unit for close observation. Outcome was not reported. Documents held by sender: None.
Age: 8.0
Sex: M
Vaccine: FLU(H1N1), FLUX(H1N1)
Symptoms: Blood product transfusion, Diarrhoea, Gastroenteritis viral, Guillain-Barre syndrome, Muscular weakness
Clinical narrative: Initial case received from the CDC on 08 January 2010, VAERS ID number 376046-1. An 8-year-old male patient received H1N1 (manufacturer and lot number unknown) on 20 October 2009. Past medical history and medication history was not reported. On 17 December 2009, 58 days post-vaccination, he experienced stomach flu with vomiting and diarrhea. Viral gastroenteritis was a coded adverse event in the report received. On 27 December 2009, 68 days post-vaccination, he presented with weakness in his extremities and was diagnosed with Guillain-Barre Syndrome. He was hospitalized and treated with IVIg. The patient subsequently recovered. No additional information was reported.
Age: 8.0
Sex: M
Vaccine: FLU(H1N1), FLUX(H1N1)
Symptoms: Vomiting
Clinical narrative: Initial case received from the CDC on 08 January 2010, VAERS ID number 376046-1. An 8-year-old male patient received H1N1 (manufacturer and lot number unknown) on 20 October 2009. Past medical history and medication history was not reported. On 17 December 2009, 58 days post-vaccination, he experienced stomach flu with vomiting and diarrhea. Viral gastroenteritis was a coded adverse event in the report received. On 27 December 2009, 68 days post-vaccination, he presented with weakness in his extremities and was diagnosed with Guillain-Barre Syndrome. He was hospitalized and treated with IVIg. The patient subsequently recovered. No additional information was reported.
Age: 55.0
Sex: M
Vaccine: FLU(H1N1), FLU(H1N1)
Symptoms: Diplopia, Dysphagia, Eyelid ptosis, Fatigue, Hypoaesthesia
Clinical narrative: dizziness, general weakness, blurry vision, extremity numbness
Age: 55.0
Sex: M
Vaccine: FLU(H1N1), FLU(H1N1)
Symptoms: Muscular weakness, Nasopharyngitis, Rhinorrhoea
Clinical narrative: dizziness, general weakness, blurry vision, extremity numbness
Age: 55.0
Sex: M
Vaccine: FLU(H1N1), FLU(H1N1)
Symptoms: Asthenia, CSF protein increased, Dizziness, Electromyogram abnormal, Hypoaesthesia
Clinical narrative: dizziness, general weakness, blurry vision, extremity numbness
Age: 55.0
Sex: M
Vaccine: FLU(H1N1), FLU(H1N1)
Symptoms: Lumbar puncture abnormal, Vision blurred
Clinical narrative: dizziness, general weakness, blurry vision, extremity numbness
Age: 46.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Pruritus, Rash erythematous, Urticaria
Clinical narrative: I received the H1N1 vaccine on 1/22/2010. Adverse events occured on 1/25/2010 to present. Red bumps appeared on my back and in the front of my torso, arms, stomach etc.  Red bumps became huge welts all over my body. Size of welts ranged from 3 inches in height to 6 inches in width and greater and vice versa.  The hives have been traveling up to my neck to the soles of my feet,arms, thighs, legs, and hands, etc.  Very, very, very, itchy.  Seems to worsen in the evening.   Treatment:  Soaked in tub with baking soda on first day.  On second day used Hydrocortisone and Benadryl. On the third day went to the doctors.  He said to continue with what I was doing.  Called doctor today and said that the hives were still bothering me. Doctor called in prescription for predisone today.  I will pick up prescription tomorrow. Hives are continuing up to today 1/28/2010
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Swelling of left deltoid muscle, very red tender, 3.5 x 4.0 cm size.
Age: 59.0
Sex: U
Vaccine: FLU3
Symptoms: Pain in extremity, Vaccination complication, X-ray
Clinical narrative: On October 14, 2008 I received an Influenza flu shot at a local store for $25.00 and administered by the Pharmacy Dept. Since that date, I have experienced adverse side effects of the shot with extreme pain to my left arm and limited range of motion. I reported adverse effects on 11/21/09 and 01/08/10 and Jan 13, 2010-Report to Novartis.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Diarrhoea, Nausea, Pruritus
Clinical narrative: Received flu vaccine and approx 20 minutes later experienced chest tightness, itching- not sure if rash, a little nausea and diarrhea.  Approx 5 min later took 25-50mg of PO Benadryl and symptoms subsided apprx 30-40 min. later.
Age: 1.05
Sex: F
Vaccine: HIBV, MMR, UNK, VARCEL
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Dorsum of left thigh there is an area of 1 1/2 in. in diameter erythema.  Warm to touch.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Rt arm "swollen, red, warm, sore to touch. Less red than yesterday"  Denies fever, using extremity without pain.  Recommended Tylenol or Ibuprofen and warm compresses for discomfort.  Suggested child see physician is no improvement.
Age: 38.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site streaking, Injection site swelling
Clinical narrative: TDAP to L deltoid on 1/13/2010. Pt returned to clinic on 1/15/2010 with swelling at injection site 5cm x 4cm raised, red and streaky area.
Age: 6.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Rash erythematous
Clinical narrative: Fine, flat red rash to lower arms and left cheek; patient denied itching; mother states rash occurred the same day after vaccine was received.
Age: 15.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Fatigue, Somnolence
Clinical narrative: TC from mother stating that son came home from school c/o extreme tiredness. States went to bed and slept about 4 hours. Brother had same vaccine and had fainted and c/o tiredness when home from school. Both went to school today.
Age: 5.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Erythema, Rash generalised
Clinical narrative: Shortly after receiving the vaccine. Patient developed a full body rash - flat and red. She had also just finished an Rx of AUGMENTIN for strep throat.
Age: 52.0
Sex: F
Vaccine: PPV
Symptoms: Back pain, Headache, Injection site pain, Neck pain, Pain in extremity
Clinical narrative: Pain down arm of injection within 1 hour. Then up into shoulder and progressed into neck and down to left low back within several hours. Lasted 5 days. Also had headache.
Age: 19.0
Sex: F
Vaccine: FLU3
Symptoms: Chest pain, Dyspnoea, Rash, Swollen tongue, Urticaria
Clinical narrative: Rash, hives, SOB, chest pain, sensation of tongue swelling
Age: 1.76
Sex: F
Vaccine: FLUX(H1N1), FLU(H1N1)
Symptoms: Blepharospasm, Corneal reflex decreased
Clinical narrative: Uncontrollable eye twitching/ blinking of both eyes. No outcome as of yet, looking for answers...
Age: 1.76
Sex: F
Vaccine: FLUX(H1N1), FLU(H1N1)
Symptoms: Blepharospasm, Excessive eye blinking
Clinical narrative: Uncontrollable eye twitching/ blinking of both eyes. No outcome as of yet, looking for answers...
Age: 23.0
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: Cold sweat, Dry mouth, Dyspnoea, Oropharyngeal pain
Clinical narrative: Woke up with cold sweat and severe dry mouth, and sore throat, as well as having a moderately hard time to breathe.
Age: 15.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Fatigue, Weight decreased
Clinical narrative: 2 days after receiving the H1N1 vaccine, child became very tired all the time. He didn't want to wake up or eat. Parents made him eat even when he was half asleep. Lasted over a month. Mom states he is eating better at home now but still does not eat well at school. School feels he has become very thin and muscles appear "wasted".
Age: 0.45
Sex: M
Vaccine: HEP, RV1
Symptoms: Abdominal pain upper, Intussusception, Vomiting
Clinical narrative: 12/16/09 ROTARIX #1-developed belly pain and vomiting. 1/20/10 ROTARIX #2-on 1/23/10 intussusception.
Age: 77.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Muscular weakness, Oedema peripheral, Skin warm
Clinical narrative: arm became red, swollen and hot to the touch Redness extended down entire arm. Lasted for about 4 days. Resolved today. was sl weak also, strength almost normal
Age: 1.51
Sex: F
Vaccine: DTAP, HEPA
Symptoms: Injection site discolouration, Injection site erythema
Clinical narrative: DTAP given 1/12/10 + mother called 1/15/10 to review Sx. Pt's leg left thigh @ injection site was red approx 6 inches, resolved this 1/15/10- mild distortion at area. Reported by phone call from parent.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Erythema, Skin warm, Swelling, Vaccination complication
Clinical narrative: Taken to hospital ER for right thigh red, swollen, on 1/23/10 and again on 1/24/10 due to increasing redness and hot to touch. Started on KEFLEX (1/23), and later on BACTRIM (1/24) with one dose of ceftriaxone given in ER. Today (1/25/10)- seen in physician office. Family reports has been taking BENADRYL for itch. Dr dic'd KEFLEX. Her diagnosis is localized allergic reaction to immunization.
Age: 66.0
Sex: F
Vaccine: PPV, TD
Symptoms: Erythema, Injected limb mobility decreased, Injection site erythema, Injection site swelling, Pain
Clinical narrative: Day 1 Painful to lift arm 5 hours later, tender to touch Day 2 red skin warm to touch swollen. Advil for pain difficult to rotate arm or lift. Day 3 warm, (Ice on Day 2,3.) tender, red less swelling. Less red tender Day 4, 5. See diagram drawn by reporter.
Age: 66.0
Sex: F
Vaccine: PPV, TD
Symptoms: Skin warm, Tenderness
Clinical narrative: Day 1 Painful to lift arm 5 hours later, tender to touch Day 2 red skin warm to touch swollen. Advil for pain difficult to rotate arm or lift. Day 3 warm, (Ice on Day 2,3.) tender, red less swelling. Less red tender Day 4, 5. See diagram drawn by reporter.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Biopsy, Lesion excision
Clinical narrative: Despite vaccinations pt. developed a high grade lesion which had to be treated with laser.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Cough, Wheezing
Clinical narrative: Patient developed cough and wheeze within 15 minutes of vaccine administration.
Age: 66.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Asthenia, Decreased appetite, Dysphagia, Increased upper airway secretion, Nausea
Clinical narrative: The patient described having a severe sore throat, problems swallowing, phlegm in throat, nausea, weakness, lost of appetite, hives on both hands and arms with severe itching. The pt did not go to ER or PCP. The pt. stated that he did take SYPHRO.
Age: 66.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Oropharyngeal pain, Pruritus, Urticaria
Clinical narrative: The patient described having a severe sore throat, problems swallowing, phlegm in throat, nausea, weakness, lost of appetite, hives on both hands and arms with severe itching. The pt did not go to ER or PCP. The pt. stated that he did take SYPHRO.
Age: 0.38
Sex: M
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: No adverse event observed. Pt received Rotavirus is not to be administered after 14 weeks and 6 days. (Administrator event)
Age: 84.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Heart rate increased
Clinical narrative: rapid heart rate for 2 days.
Age: 52.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Arthralgia, Chest discomfort, Chest pain, Chills, Headache
Clinical narrative: Joint aches with chills, tightness and burning of chest, headache, duration of 20 hours began 1 day after vaccination.
Age: 51.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Urticaria
Clinical narrative: 45 min after vaccine was administered, pt exported hives on face and neck; denied SOB; p: 72 R- 12: No hx of adverse reaction to seasonal flu vaccine; reports past reaction to allergy shots" advised to offer future flu shots with being tested for sensitivity to them. urged to contact MD.
Age: 36.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Drug exposure during pregnancy, Intra-uterine death
Clinical narrative: Fetal Demise inside the pregnant mother at 5 weeks and 3 days, less than two months after taking the vaccine. Was alive on 12/30/2009 and discovered no heart beats on 01/05/2010
Age: 65.0
Sex: M
Vaccine: FLU(H1N1), FLUX, PPV
Symptoms: Asthenia, Blood thyroid stimulating hormone, Body temperature increased, Cardiac enzymes, Electrocardiogram normal
Clinical narrative: 98 DEGREES, 116-20, 90  WEAKNESS, NAUSEA, PROFOUND FATIGUE, FALLING ASLEEP-THESE SYMPTOMS STARTED 8-12 HOURS AFTER RECEIVING H1N1, SEASONAL AND PNEUMOCOCCAL VACCINES.  TREATED WITH 1000 CC IV FLUIDS, VITAMIN B-12 1000 MG IM
Age: 65.0
Sex: M
Vaccine: FLU(H1N1), FLUX, PPV
Symptoms: Fatigue, Full blood count normal, Nausea, Protein total decreased, Somnolence
Clinical narrative: 98 DEGREES, 116-20, 90  WEAKNESS, NAUSEA, PROFOUND FATIGUE, FALLING ASLEEP-THESE SYMPTOMS STARTED 8-12 HOURS AFTER RECEIVING H1N1, SEASONAL AND PNEUMOCOCCAL VACCINES.  TREATED WITH 1000 CC IV FLUIDS, VITAMIN B-12 1000 MG IM
Age: 65.0
Sex: M
Vaccine: FLU(H1N1), FLUX, PPV
Symptoms: Urine analysis normal
Clinical narrative: 98 DEGREES, 116-20, 90  WEAKNESS, NAUSEA, PROFOUND FATIGUE, FALLING ASLEEP-THESE SYMPTOMS STARTED 8-12 HOURS AFTER RECEIVING H1N1, SEASONAL AND PNEUMOCOCCAL VACCINES.  TREATED WITH 1000 CC IV FLUIDS, VITAMIN B-12 1000 MG IM
Age: 30.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Abdominal pain, Pregnancy test negative, Pyrexia, Vomiting
Clinical narrative: 11/12 - sudden onset severe abdominal pain and fever (no nausea) and vomiting x 11 hrs. 11/14 - sudden on set abdominal pain and vomiting x 8 hrs. 11/15, 11/17, 11/19, 11/20, 11/22, 11/23, 11/25, 11/26, 11/29, 11/30, 12/2, 12/3 - sudden onset abdominal pain x about 5 hrs each day with intermittent vomiting.
Age: 65.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Hypokinesia, Injection site inflammation, Injection site pain
Clinical narrative: Vaccination received 1/8/2010. Injection was unusually painful and arm has gotten progressively more painful since then. Upper arm hurts and patient says can barely move it. DX: Injection site tissue inflammation.
Age: 5.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Erythema, Injection site erythema, Injection site warmth
Clinical narrative: 2 x 2 red, raised and hot area around injection site, that lasted for about 7 days.
Age: 39.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Back pain, Chest discomfort, Dizziness, Dry mouth, Dyspnoea
Clinical narrative: 1-14-10 Late afternoon-fatigue, feverish, nausea-woke 1 AM-HR 162, nausea, vomit and increased back pain over L kidney area. Injection site normal-no swell, no redness. 1-15-10 3PM vomit, chest tight, HR 137, mouth, lips are dry. No hives, dizziness, wheezing, SOB. Tried ginger in water-eased nausea-drink water, powerade. No further vomit. 1-16-10 HR 80-no further symptoms. He felt "ginger and fluid flushed problem from system". No hx of kidney stones/problems
Age: 39.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Fatigue, Nausea, Pyrexia, Vomiting, Wheezing
Clinical narrative: 1-14-10 Late afternoon-fatigue, feverish, nausea-woke 1 AM-HR 162, nausea, vomit and increased back pain over L kidney area. Injection site normal-no swell, no redness. 1-15-10 3PM vomit, chest tight, HR 137, mouth, lips are dry. No hives, dizziness, wheezing, SOB. Tried ginger in water-eased nausea-drink water, powerade. No further vomit. 1-16-10 HR 80-no further symptoms. He felt "ginger and fluid flushed problem from system". No hx of kidney stones/problems
Age: 33.0
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Headache, Hypoaesthesia, Nuclear magnetic resonance imaging
Clinical narrative: Had H1N1, 10/26/09, Seasonal 10/28/09. About 1/2 week later, arms, hands, legs, feet became numb. Seen by ER/PCP - given MEDROL dose pack Prednisone. Taking LYRICA with improvement. Now seeing neurologist 1/7/10 - was told by him this was due to H1N1 vaccine. Burning persists both hands and feet, also has headaches.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Abnormal behaviour, Autism, Immediate post-injection reaction
Clinical narrative: Information has been received from a consumer concerning her friend's son, a 4 year old male who on an unspecified date was vaccinated with MMR II. Subsequently the patient developed autism right after receiving the vaccine. The patient was not functioning as normal kid as per the reporter. The patient's autism persisted. Upon internal review, autism was considered to be an other important medical event. This is one of the several reports from the same source. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Autism, Kleihauer-Betke test
Clinical narrative: Information has been received from a physician via the internet concerning a male patient with egg allergy. On an unspecified date the patient was vaccinated with a dose of MMR II. The patient developed autism after the MMR II. At the time of the report the patient's outcome was unknown. It was unknown if the patient sought medical attention.  Upon internal review autism was considered to be an other important medical event. No further information is available.
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Cellulitis, Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Initial case received from a health care professional on 14 December 2009; case was initially assessed as non-serious. Based upon new information received from the health care professional on 25 January 2010, the case has been upgraded to serious. A 52-year-old female patient received an intramuscular right deltoid injection of ADACEL (sanofi pasteur inc lot number U2937DA, sanofi pasteur ltd lot number C3160) on 09 December 2009. Medical history included bronchitis, reactive airway disease, sinusitis, and chronic monocytic leukemia (in remission.). The patient was a smoker, and had recently experienced a laceration on her hand from a file cabinet. Concomitant medications included VIVELLE, PROMETRIUM, COZAAR, VALTREX, AMITRIPTYLINE, VISTARIL, CELEBREX, AMBIEN, ZYRTEC, NASONEX, and ALBUTEROL as needed. Two days post vaccination, she experienced a fever and red raised area at the injection site. She presented to the emergency department on 12 December 2009, she was diagnosed with cellulitis, treated with intravenous antibiotics, and subsequently released. She was seen in follow-up by her physician on 18 December 2009, at which time the cellulitis was considered to be resolved. She was noted to have faint erythema in the right deltoid present in the entire distribution, but the area was not tender and shoulder range of motion and strength were normal. Oral antibiotics were ongoing at that time, but the event was recovered. Documents held by sender: Office note.
Age: 20.0
Sex: F
Vaccine: HEP, HEPA
Symptoms: Injection site swelling, Nervousness, Pyrexia, Rash, Skin discolouration
Clinical narrative: 1 yr ago had Hep A, B influenza, tetanus. Patient reported she had vomiting/fever/swelling at site with last series a 1yr ago. Contacted doctor to discuss. It was agreed to give only Hep and Hep B today. 15 min after administration patient stated she felt shaky-trembling noted. BP 140/100, P 88, R18. Had her lie down, co-worker of patient gave her Benadryl 125mg po 0920 0930 and tremors, rash appearing on back , and around ears. Taken to hospital by friend.
Age: 20.0
Sex: F
Vaccine: HEP, HEPA
Symptoms: Tremor, Vomiting
Clinical narrative: 1 yr ago had Hep A, B influenza, tetanus. Patient reported she had vomiting/fever/swelling at site with last series a 1yr ago. Contacted doctor to discuss. It was agreed to give only Hep and Hep B today. 15 min after administration patient stated she felt shaky-trembling noted. BP 140/100, P 88, R18. Had her lie down, co-worker of patient gave her Benadryl 125mg po 0920 0930 and tremors, rash appearing on back , and around ears. Taken to hospital by friend.
Age: 1.01
Sex: M
Vaccine: PNC
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: 6 x 2 cm redness at injection site of Prevnar 10 days after immuniz tender to touch. Appears to be muscular Rx only. Tx Cool compress and Motrin.
Age: 47.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash pruritic
Clinical narrative: pruritic body rash
Age: 16.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Back pain, Chest pain, Chills, Headache, Respiratory disorder
Clinical narrative: PATIENT REFERS: BACK AND CHEST PAIN, HEADACHE, CHILLS, RESPIRATORY PROBLEMS.
Age: 54.0
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: Arthralgia, Headache, Impaired work ability, Myalgia, Nausea
Clinical narrative: Symptoms:  strong muscle and joint aches, sporadic headache, short time of ringing in ears, and some nausea. Due to symprtoms, I could not work at my office job for an entire day (1/7/10). Treatment:  aspirin & ibuprofen, sleep. Time course:  1/7 was worst date for symptoms.  I felt 100% recovered by 1/8/10 at 3:00 PM.
Age: 54.0
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: Tinnitus
Clinical narrative: Symptoms:  strong muscle and joint aches, sporadic headache, short time of ringing in ears, and some nausea. Due to symprtoms, I could not work at my office job for an entire day (1/7/10). Treatment:  aspirin & ibuprofen, sleep. Time course:  1/7 was worst date for symptoms.  I felt 100% recovered by 1/8/10 at 3:00 PM.
Age: 33.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Musculoskeletal pain
Clinical narrative: Woke up in am on 1/27/10 with c/o pain to R shoulder.  Upon inspection found large lump approx 5cm in diameter to R deltoid along with redness extending slightly beyond lump area.  Today lump and redness continue to be present.  States that pain is better but is tender and sensitive.
Age: 2.0
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Injection site swelling, Injection site warmth, Urticaria
Clinical narrative: Hives, systemic Right thigh @ site of varicella vaccine swollen, warm and raised.
Age: 41.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Influenza like illness, Urticaria
Clinical narrative: Hives all over flu like symptoms
Age: 14.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Abortion spontaneous, Drug exposure during pregnancy, Menstruation irregular
Clinical narrative: Information has been received from a nurse practitioner for the pregnancy Registry for GARDASIL concerning a 14 year old female patient with hypertension who on 13-OCT-2008 was vaccinated with her first dose of GARDASIL (Lot#660612/0229X) by intramuscular route and a dose of VARIVAX (lot and route not reported). Concomitant therapy included influenza virus vaccine (unspecified) and DTaP (unspecified). On 09-DEC-2008 the patient received her second dose of GARDASIL (Lot# 660612/0229X). As of 15-DEC-2008, the patient was eight weeks pregnant (LMP 20-OCT-2008, EDD 27-JUL-2009). The patient reported no symptoms. Follow up information has been received for a health care professional who clarified the patient's EDD of 27-JUL-2009 from the initial report. 09-DEC-2009, the patient received her second dose of GARDASIL and shortly after that the patient had a miscarriage. It was also reported that the patient had some irregular periods and got pregnant again (WAES# 1001USA03249). The patient did not have any GARDASIL between the pregnancies and will have her third dose when the patient returns to the office and it is confirmed that she is not pregnant. Additional information is not expected.
Age: 57.0
Sex: M
Vaccine: DTOX, PER, TTOX
Symptoms: Headache, Oropharyngeal pain, Pain in extremity, Upper respiratory tract congestion
Clinical narrative: sore arm, headache, sore throat, congested chest increased over the next 48 hours
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Blood creatine phosphokinase increased, Blood culture, Full blood count normal, Hypoaesthesia, Injection site erythema
Clinical narrative: Member noted usual redness around the site of vaccination 26JAN10. On the eve of 27JAN10, noted his arm was red, itchy, and swollen with numbness in left hand. Seen in urgent care center @ Hospital. He was given IV fluids and Levaquin 500mg per IV. He did have Labs drawn (CBC,blood cultures, CK) He was released and sent back to training with followup in clinic next day.
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Oedema peripheral, Pruritus
Clinical narrative: Member noted usual redness around the site of vaccination 26JAN10. On the eve of 27JAN10, noted his arm was red, itchy, and swollen with numbness in left hand. Seen in urgent care center @ Hospital. He was given IV fluids and Levaquin 500mg per IV. He did have Labs drawn (CBC,blood cultures, CK) He was released and sent back to training with followup in clinic next day.
Age: 35.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Antimitochondrial antibody normal, Drug exposure during pregnancy, Foetal growth retardation, Ultrasound antenatal screen abnormal
Clinical narrative: Pt LMP 7/29/09.  Vaccinated first trimester.  Early-onset IUGR noted (by 22nd week gestation) in fetus after serial first trimester ultrasounds had shown appropriate interval growth.
Age: 1.13
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: C-reactive protein normal, Cerebral atrophy, Cerebral ventricle dilatation, Complex partial seizures, Computerised tomogram abnormal
Clinical narrative: Afebrile Complex Partial Seizure lasting 20 minutes with Todd's Paralysis of 6th and 7th Cranial nerves on right.  CBC, CMP, CRP, Electrolytes, EEG, LFT within normal limits.  CT Scan with Cerebral Atrophy including large lacunae in left frontal lobe; no acute bleed; no SOL.  Transferred from one hospital to another for Pediatric neurology.  Observed overnight with resolution of Todd's paralysis and discharged home the following day.
Age: 1.13
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Condition aggravated, Convulsion, Cranial nerve paralysis, Electroencephalogram normal, Full blood count normal
Clinical narrative: Afebrile Complex Partial Seizure lasting 20 minutes with Todd's Paralysis of 6th and 7th Cranial nerves on right.  CBC, CMP, CRP, Electrolytes, EEG, LFT within normal limits.  CT Scan with Cerebral Atrophy including large lacunae in left frontal lobe; no acute bleed; no SOL.  Transferred from one hospital to another for Pediatric neurology.  Observed overnight with resolution of Todd's paralysis and discharged home the following day.
Age: 1.13
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Liver function test normal, Metabolic function test, Postictal paralysis, Scan brain
Clinical narrative: Afebrile Complex Partial Seizure lasting 20 minutes with Todd's Paralysis of 6th and 7th Cranial nerves on right.  CBC, CMP, CRP, Electrolytes, EEG, LFT within normal limits.  CT Scan with Cerebral Atrophy including large lacunae in left frontal lobe; no acute bleed; no SOL.  Transferred from one hospital to another for Pediatric neurology.  Observed overnight with resolution of Todd's paralysis and discharged home the following day.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Abortion induced, Blood human chorionic gonadotropin positive, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received from a physician concerning an 18 year old female with no known medical history and drugs allergies, who on 24-APR-2009 was vaccinated with a 0.5 ml first dose of GARDASIL, intramuscularly. There was no concomitant medication. On 27-APR-2009 the patient discovery that she was pregnant. No adverse effects reported. The patient had a urine pregnancy test at office that was positive. The pregnancy was confirmed with a blood test. The patient LMP was on 01-APR-2009 and her estimated delivery date will be on 06-JAN-2010. The patient sought medical attention through an office visit. Follow up information received from a physician indicated that the patient was a female. On 09-MAY-2009 the patient had an elective termination of her pregnancy. It was unknown if the products of conception were examined or if the fetus was normal. The patient's outcome was unknown. Upon internal review elective termination was determined to be another important medical event. No further information is available.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, Drug screen positive, Premature labour
Clinical narrative: Information has been received from a physician for the Pregnancy Registry for GARDASIL, concerning a 17 year old female with a medical history of vaccine exposure to pregnancy (WAES #0901USA01198) who on 11-DEC-2008 was vaccinated with one dose of GARDASIL (lot # 660391/0063X) IM in her deltoid. After the vaccine exposure to the initial pregnancy, the patient transferred from the physician's care another location. The physician reported that according to social workers at this agency, the patient delivered on 17-DEC-2009, which was three months early from her due date. The date of LMP was determined to be in June 2009 and EDD was approximately 17-MAR-2010. The physician thought this pregnancy was a different pregnancy from the initial one reported given the dating conflict. The physician added that the mother tested positive for marijuana at that time, and that "there were a lot of other things going on" with this young mother. The physician did not have information on the health and outcome of the baby. Upon internal review, premature labour was considered to be an other important medical event. The baby's experience has been captured in WAES #1001USA02981B1. No further information is available.
Sex: U
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, Premature baby
Clinical narrative: Information has been received from a physician for the Pregnancy Registry for GARDASIL, concerning a 17 year old female with a medical history of previous pregnancy (WAES #0901USA01198) who on 11-DEC-2008 was vaccinated with one dose of GARDASIL (lot # 660391/0063X) IM in her deltoid. After the vaccine exposure to the initial pregnancy, the patient transferred from the physician's care to another location. Physician reported that according the social workers at this agency, the patient delivered on 17-DEC-2009, which was three months early from her due date. The physician did not have information on the health and outcome of the baby. Upon internal review, premature baby was considered to be an other important medical event. The mother's experience has been captured in WAES #1001USA02981. No further information is available.